Pilot randomized active-placebo-controlled trial of low-dose ketamine for the treatment of multiple sclerosis-related fatigue

Fatigue is the most common symptom of MS and has no effective pharmacotherapy. To determine the tolerability, safety, and efficacy of low-dose ketamine infusion for MS-related fatigue. In this double-blind, randomized, active-placebo-controlled trial, 18 subjects with multiple sclerosis (MS) and rep...

Celý popis

Podrobná bibliografia

Vydané v:	Multiple sclerosis Ročník 27; číslo 6; s. 942
Hlavní autori:	Fitzgerald, Kathryn C, Morris, Bridget, Soroosh, Aurash, Balshi, Alexandra, Maher, Dermot, Kaplin, Adam, Nourbakhsh, Bardia
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England 01.05.2021
Predmet:	Double-Blind Method Fatigue - drug therapy Fatigue - etiology Humans Ketamine - adverse effects Multiple Sclerosis - complications Multiple Sclerosis - drug therapy Pilot Projects Treatment Outcome Multiple sclerosis fatigue ketamine midazolam randomized controlled trial
ISSN:	1477-0970, 1477-0970
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!